Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy

NCT07528716 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: SHR- A1811
DRUG: PCbHP
DRUG: SHR- A1811+ Pyrotinib

Sponsor

Fudan University